Lenalidomide desensitization for delayed hypersensitivity reactions in 5 patients with multiple myeloma

Br J Haematol. 2014 Oct;167(1):127-31. doi: 10.1111/bjh.12925. Epub 2014 May 14.

Authors

Min Jung Lee¹, Paige Wickner, Laura Fanning, Robert Schlossman, Paul Richardson, Jacob Laubach, Maria Castells

Affiliation

¹ Division of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. mlee42@partners.org.

PMID: 24824093
DOI: 10.1111/bjh.12925

No abstract available

Keywords: allergy; desensitization; lenalidomide; multiple myeloma; myeloma therapy.

Publication types

Case Reports
Letter

MeSH terms

Desensitization, Immunologic*
Drug Hypersensitivity / etiology*
Drug Hypersensitivity / therapy*
Female
Humans
Hypersensitivity, Delayed / etiology*
Hypersensitivity, Delayed / therapy*
Immunologic Factors / administration & dosage
Immunologic Factors / adverse effects*
Immunologic Factors / therapeutic use
Lenalidomide
Male
Middle Aged
Multiple Myeloma / complications*
Multiple Myeloma / drug therapy
Thalidomide / administration & dosage
Thalidomide / adverse effects
Thalidomide / analogs & derivatives*
Thalidomide / therapeutic use
Treatment Outcome

Substances

Immunologic Factors
Thalidomide
Lenalidomide